Activation of the transcription factor NRF2 mediates the anti-inflammatory properties of a subset of over-the-counter and prescription NSAIDs.
Activation of the transcription factor NRF2 mediates the anti-inflammatory properties of a subset of over-the-counter and prescription NSAIDs.
复制标题
DOI:
10.1016/j.immuni.2022.04.015
复制
发表时间:
2022-06-14
期刊:
影响因子:
32.4
通讯作者:
Wang, Andrew
中科院分区:
文献类型:
--
作者:
Eisenstein, Anna;Hilliard, Brandon K.;Pope, Scott D.;Zhang, Cuiling;Taskar, Pranali;Waizman, Daniel A.;Israni-Winger, Kavita;Tian, Hui;Luan, Harding H.;Wang, Andrew
Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenase (COX) enzymes and are ubiquitously used for their anti-inflammatory properties. However, COX inhibition alone fails to explain numerous clinical outcomes of NSAID usage. Screening commonly used NSAIDs in primary human and murine myeloid cells demonstrated that NSAIDs could be differentiated by their ability to induce Growth/differentiation factor 15 (GDF15), independent of COX specificity. Using genetic and pharmacologic approaches, NSAID-mediated GDF15 induction was dependent on activation of Nuclear factor erythroid 2-related factor 2 (NRF2) in myeloid cells. Sensing by Cysteine 151 of the NRF2 chaperone, Kelch-like ECH-associated protein 1 (KEAP1) was required for NSAID activation of NRF2 and subsequent anti-inflammatory effects both in vitro and in vivo. Myeloid-specific deletion of NRF2 abolished NSAID-mediated tissue protection in murine models of gout and endotoxemia. This highlights a noncanonical NRF2-dependent mechanism of action for the anti-inflammatory activity of a subset of commonly used NSAIDs. The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is ubiquitous. Herein, Eisenstein et al identify a noncanonical mechanism of action for the anti-inflammatory activity of NSAIDs through activation of the transcription factor, Nuclear factor erythroid 2-related factor 2 (NRF2). In endotoxemia and gout models, indomethacin improved inflammation in an NRF2-dependent manner.
登录
查看更多内容
DOI:
10.1056/nejmoa1306033
发表时间:
2013-12-26
期刊:
The New England journal of medicine
影响因子:
--
作者:
de Zeeuw D;Akizawa T;Audhya P;Bakris GL;Chin M;Christ-Schmidt H;Goldsberry A;Houser M;Krauth M;Lambers Heerspink HJ;McMurray JJ;Meyer CJ;Parving HH;Remuzzi G;Toto RD;Vaziri ND;Wanner C;Wittes J;Wrolstad D;Chertow GM;BEACON Trial Investigators
通讯作者:
BEACON Trial Investigators
影响因子:
9.3
作者:
Foresti, Roberta;Bains, Sandip K.;Motterlini, Roberto
通讯作者:
Motterlini, Roberto
DOI:
10.1073/pnas.172398899
发表时间:
2002-09-03
影响因子:
11.1
作者:
Dinkova-Kostova, AT;Holtzclaw, WD;Talalay, P
通讯作者:
Talalay, P
影响因子:
2.2
作者:
Abram CL;Roberge GL;Hu Y;Lowell CA
通讯作者:
Lowell CA
影响因子:
168.9
作者:
da Costa, Bruno R.;Reichenbach, Stephan;Trelle, Sven
通讯作者:
Trelle, Sven